- In MS, HSCT Stems Long-term Disability
- Relapsing-Remitting MS: Disability After 15 Years of DMT
- Multiple Sclerosis Relapse: What Month Is It?
- In Relapsing MS, Early and Long-Term Treatment Delays Disability and Progression
- Multiple Sclerosis and Cancer: Some Good News, Some Not
- Q&A: MS Prodrome?
- Q&A: Central Vein Sign: A Promising Imaging Biomarker in MS?
- Myelin Blistering and Its Role in the Pathophysiology of Multiple Sclerosis
- Multiple Sclerosis and Cognitive Impairment: What Causes it?
- MRI in Multiple Sclerosis: New Guidelines
- Gray Matter Atrophy and White Matter Lesions in Relapsing-Remitting MS
- How Does the Central Vein Sign Aid in Treating Multiple Sclerosis?
- In Patients with MS, Gut Microbiota and Blood Metabolome Alterations Identified
- COVID-19 Reimmunization in MS: Should It Be Considered?
- Quick Quiz: How Would Your MS Patients Answer These Questions?
- In MS, What is the Role of Ileal Conduit in Patients with Lower Urinary Tract Dysfunction?
- Patients with MS Have More Fractured Hips, More Falls, and are More Likely to Receive an Osteoporosis Diagnosis
- Multiple Sclerosis and the Risk of Relapse After IVF
- Keeping MS Patients with Comorbidities Out of the Hospital
- Multiple Sclerosis and Stroke: Discharge Outcomes and Hyperacute Stroke Treatment
- Predicting Cognitive Impairment in MS
- What Stops People with MS from Exercising—and Can You Help?
- COVID-19 Infections in Patients on Highly Effective Treatments
- The Gut Microbiome in Patients with MS
- Reparative Therapy in Multiple Sclerosis: Early but Promising
- Can We Modify Bacteria in the Gut—and Change the Course of MS?
- Monitoring Patients with Radiologically Isolated Syndrome: What’s Appropriate?
- Clinically Isolated Syndrome: What is it?
- Clinically Isolated Syndrome: How to Manage it
- When Should DMT Be Stopped?
- Neuropathic Pain: What Causes it?
- Neuropathic Pain: How to Manage it
- B-Cell Depleting Therapies: The Most Promising Development in MS?
- Patient Perspectives of MS: Treatment Goals
- Vitamin D Supplementation for MS Patients
- Abnormal Brain Scans vs Radiologically Isolated Syndrome: What You Should Know
- Applications of aHSCT: Who’s Eligible?
- How Patient-Specific Factors Influence MS Risk and Progression
- In MS, MRI Trumps Clinical Attacks for Detecting Inflammatory Activity
- Making the Most of MRI in Multiple Sclerosis
- Multiple Sclerosis: Q&A on Aquatic Exercise
- Q&A: Benjamin M. Segal, MD, on Aging and MS